- Featured Product
- KD/KO Validated
Cyclin B2 Monoclonal antibody, PBS Only
Cyclin B2 Monoclonal Antibody for WB, IHC, IF/ICC, IF-P, Indirect ELISA
Host / Isotype
Mouse / IgG2a
Reactivity
human, mouse
Applications
WB, IHC, IF/ICC, IF-P, Indirect ELISA
Conjugate
Unconjugated
CloneNo.
2G8B7
Cat no : 67726-1-PBS
Synonyms
Validation Data Gallery
Product Information
67726-1-PBS targets Cyclin B2 in WB, IHC, IF/ICC, IF-P, Indirect ELISA applications and shows reactivity with human, mouse samples.
Tested Reactivity | human, mouse |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Immunogen | Cyclin B2 fusion protein Ag16329 |
Full Name | cyclin B2 |
Calculated Molecular Weight | 398 aa, 45 kDa |
Observed Molecular Weight | 45 kDa |
GenBank Accession Number | BC105086 |
Gene Symbol | Cyclin B2 |
Gene ID (NCBI) | 9133 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS Only |
Storage Conditions | Store at -80°C. |
Background Information
Cyclin B2 (CCNB2) is a member of cyclin family proteins, which regulate the activities of cyclin dependent kinases (CDKs) and different cyclins function spatially and temporally in specific phases of the cell cycle. Cyclin B2 serves a key role in progression of G2/M transition. Cyclin B2 has been found to be up-regulated in a variety of human cancers, such as adrenocortical carcinoma, breast carcinoma, colorectal adenocarcinoma, pituitary adenoma and gastric cancer. The aberrant expression of Cyclin B2 deregulates spindle checkpoints in the cell cycle and results in chromosomal instability (CIN), one of the signature phenotypes of most cancers. Moreover, serum circulating Cyclin B2 mRNA expression has been found increased in cancer patients and associated with cancer stage and metastasis status.